1. Home
  2. CYCN vs STRR Comparison

CYCN vs STRR Comparison

Compare CYCN & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • STRR
  • Stock Information
  • Founded
  • CYCN 2018
  • STRR 1985
  • Country
  • CYCN United States
  • STRR United States
  • Employees
  • CYCN N/A
  • STRR N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CYCN Health Care
  • STRR Health Care
  • Exchange
  • CYCN Nasdaq
  • STRR Nasdaq
  • Market Cap
  • CYCN 6.5M
  • STRR 6.3M
  • IPO Year
  • CYCN N/A
  • STRR N/A
  • Fundamental
  • Price
  • CYCN $2.81
  • STRR $1.93
  • Analyst Decision
  • CYCN
  • STRR Strong Buy
  • Analyst Count
  • CYCN 0
  • STRR 1
  • Target Price
  • CYCN N/A
  • STRR $5.00
  • AVG Volume (30 Days)
  • CYCN 21.8K
  • STRR 24.8K
  • Earning Date
  • CYCN 08-06-2025
  • STRR 08-12-2025
  • Dividend Yield
  • CYCN N/A
  • STRR N/A
  • EPS Growth
  • CYCN N/A
  • STRR N/A
  • EPS
  • CYCN N/A
  • STRR N/A
  • Revenue
  • CYCN $2,081,000.00
  • STRR $57,165,000.00
  • Revenue This Year
  • CYCN N/A
  • STRR $33.64
  • Revenue Next Year
  • CYCN N/A
  • STRR $22.87
  • P/E Ratio
  • CYCN N/A
  • STRR N/A
  • Revenue Growth
  • CYCN N/A
  • STRR 34.33
  • 52 Week Low
  • CYCN $1.27
  • STRR $1.72
  • 52 Week High
  • CYCN $9.47
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 41.24
  • STRR 41.41
  • Support Level
  • CYCN $3.02
  • STRR $1.95
  • Resistance Level
  • CYCN $3.16
  • STRR $2.11
  • Average True Range (ATR)
  • CYCN 0.21
  • STRR 0.09
  • MACD
  • CYCN -0.03
  • STRR -0.02
  • Stochastic Oscillator
  • CYCN 16.26
  • STRR 0.00

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: